Salvation by Registration
Copyright policy )Salvation by Registration
Robert Motzer was not happy when he learned that his manuscript about the treatment of renal cancer with sunitinib could not be considered for publication by the Journal. His paper was rejected not on the basis of the science it reported or of the Journal's editorial priorities, but because of the study's inadequate registration in the ClinicalTrials.gov database. Members of the Journal's staff routinely check the database registration of trials that are being considered for publication. The registration provided by Dr. Motzer — NCT00083889 in ClinicalTrials.gov — failed to meet the standards established by the International Committee . . .
Aged, 80 and over, Clinical Trials as Topic, Indoles, Angiogenesis Inhibitors, Kidney Neoplasms, Sunitinib, Humans, Pyrroles, Registries, Periodicals as Topic, Editorial Policies
Aged, 80 and over, Clinical Trials as Topic, Indoles, Angiogenesis Inhibitors, Kidney Neoplasms, Sunitinib, Humans, Pyrroles, Registries, Periodicals as Topic, Editorial Policies
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).98 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 1% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!